The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
Open accessAbstract
A clue to a drug's neurotoxicity?: The drug BIA 10-2474 inhibits fatty acid amide hydrolase (FAAH), a lipase that degrades a specific endocannabinoid. On the basis of this activity, BIA 10-2474 was being developed as a potential treatment for anxiety and pain. In a phase 1 trial of the drug, one subject died, and four others suffered brain damage. As an initial step in investigating whether inhibition of off-target proteins by BIA 10-2474 might contribute to its clinical neurotoxicity, van Esbroeck et al. used activity-based proteomic assays to identify proteins targeted by the drug. Studying human cells and brain samples from subjects not associated with the trial, they found that BIA 10-2474 targeted several different lipases in addition to FAAH. It also substantially altered lipid metabolism in cultured neurons. Science , this issue p. 1084
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During the period of its suspension, it was revealed that these problems were due to off-target effects of this agent that led to alterations in lipid networks in the cortexeffects which were not observed in more specific FAAH inhibitors (van Esbroeck et al., 2017).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as van Esbroeck et al., 2017
In the citing paper
“In light of the death and adverse events in other subjects given repeated high doses of the FAAH inhibitor BIA-102474-101 in a clinical trial (Kerbrat et al, 2016), it is crucial to note that this drug has multitude of off-targets, including inhibition of essential blood-clotting factors thrombin and Factor VII (van Esbroeck et al, 2017;Molinski et al, 2017), which may contributed to its toxicity.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as van Esbroeck et al, 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,143
Self-citationLong, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim‐Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 405
Self-citationHuggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375
Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 374
Self-citationA road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Lanning, B. R., Whitby, L. R., Dix, M. M., Douhan, J., Gilbert, A. M., Hett, E. C., Johnson, T., Joslyn, C. M., Kath, J. C., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1582 · Cited by 356
Self-citationBachovchin, D. A., Ji, T., Li, W., Simon, G. M., Blankman, J. L., Adibekian, A., Hoover, H. S., Niessen, S., & Cravatt, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011663107 · Cited by 274
Self-citationAnandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., PETROCELLIS, L. D., Moriello, A. S., Campi, B., McNaughton, P. A., Geppetti, P., & Marzo, V. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 243
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- A. Patat presentation at the Safety and Regulation in Early Clinical Drug Development Symposium Ghent Belgium 2 December 2016.
Cited by
Sorted by citations
Items 201–300 of 344
Proteomic tools to study drug function
Mulder, C., Leijten, N. M., & Lemeer, S. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.05.002 · Cited by 8
Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
Voorneveld, J., Florea, B. I., Bakkum, T., Mendowicz, R. J., van der Veer, M. S., Gagestein, B., van Kasteren, S. I., van der Stelt, M., Overkleeft, H. S., & Filippov, D. V. (2020) · ChemBioChem · doi:10.1002/cbic.202000042 · Cited by 8
Self-citationTargeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis
Maramai, S., & Brindisi, M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000310 · Cited by 8
Soeberdt, M., Kilić, A., & Abels, C. (2020) · Experimental Dermatology · doi:10.1111/exd.14145 · Cited by 8
Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level
Spicarova, D., & Paleček, J. (2024) · Physiological Research · doi:10.33549/physiolres.935371 · Cited by 7
Replacing Animal Tests to Improve Safety for Humans
Archibald, K., Coleman, R., & Drake, T. (2019) · BRILL eBooks · doi:10.1163/9789004391192_019 · Cited by 8
Li, G., Xu, Y., Liu, G., Zheng, M., Zhang, X., Hang, Y., & Kang, J. (2020) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202000353 · Cited by 7
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
Morgillo, C. M., Lupia, A., Deplano, A., Pirone, L., Fiorillo, B., Pedone, E. M., Luque, F. J., Onnis, V., Moraca, F., & Catalanotti, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415502 · Cited by 7
Takai, T., Jeffy, B. D., Prabhu, S., & Cohen, J. D. (2023) · Computational Toxicology · doi:10.1016/j.comtox.2023.100273 · Cited by 7
What you see is what you get: activity-based probes in single-cell analysis of enzymatic activities
Lentz, C. S. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0262 · Cited by 7
Regulatory safety pharmacology evaluation of BIA 10-2474
Hayes, A. W., Pressman, P., Moser, P. C., & Soares-da-Silva, P. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106677 · Cited by 7
Portugalov, A., & Akirav, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020730 · Cited by 8
Aspirin killed the cat: animal research models do not always apply to humans
Bell, J. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1652596 · Cited by 7
Hayes, A. W. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104541 · Cited by 7
Previously Published Phosphatase Probes have Limited Utility Due to their Unspecific Reactivity
Brake, F. H. G. T., van Luttikhuizen, S., van der Wel, T., Gagestein, B., Florea, B. I., van der Stelt, M., & Janssen, A. P. A. (2024) · ChemBioChem · doi:10.1002/cbic.202400333 · Cited by 6
Self-citationA perspective on cysteine-reactive activity-based probes
Nuber, C. M., Schwab, M. A., & Konrad, D. B. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob00905g · Cited by 6
Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease
van der Vliet, D., de Vries, L. E., Di, X., Wever, D. D., de Jong, B., van der Meij, M. T. C., van der Peet, M., Harms, A. C., Hankemeier, T., Swaab, D. F., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71083 · Cited by 6
Self-citationPlease don’t call it medical marijuana unless it is; but it probably isn’t
Witek, T. J. (2020) · Canadian Journal of Public Health · doi:10.17269/s41997-020-00333-2 · Cited by 6
Chemistry for the Identification of Therapeutic Targets: Recent Advances and Future Directions
Khiar‐Fernández, N., Macicior, J., Marcos‐Ramiro, B., & Ortega‐Gutiérrez, S. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202001507 · Cited by 7
Non-clinical toxicology evaluation of BIA 10-2474
Hayes, A. W., Weber, K., Moser, P. C., & Soares-da-Silva, P. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1867821 · Cited by 6
Serine Hydrolase Activity‐Based Probes for Use in Chemical Proteomics
Racioppo, B., Qiu, N., & Adibekian, A. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300016 · Cited by 6
Yamauchi, Y., Konno, S., Omura, N., Yoshioka, N., Hingst, A., Gütschow, M., Müller, C. E., Taguchi, A., Taniguchi, A., Kawaguchi, A., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00024 · Cited by 6
Binding-based proteomic profiling and the fatty acid amides
Merkler, D. J., & Leahy, J. W. (2018) · Trends in Research · doi:10.15761/tr.1000120 · Cited by 6
Qi, X., Ruan, C., Zhu, L., Wei, Z., Qin, J., & Xiong, J.-Q. (2026) · Nature Water · doi:10.1038/s44221-026-00646-5 · Cited by 5
Miyazawa, S., Sakai, M., Omae, Y., Ogawa, Y., Shigemori, H., & Miyamae, Y. (2024) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbae094 · Cited by 5
Opportunities for Lipid-Based Probes in the Field of Immunology
Koenders, S. T. A., Gagestein, B., & van der Stelt, M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_127 · Cited by 5
Fluorophosphonate‐Based Degrader Identifies Degradable Serine Hydrolases by Quantitative Proteomics
Field, S. D., Lee, W., Dutra, J. K., Serneo, F. F., Oyer, J. A., Xu, H., Johnson, D. S., Ende, C. W. A., & Seneviratne, U. I. (2020) · ChemBioChem · doi:10.1002/cbic.202000253 · Cited by 5
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase
Keith, J. M., Jones, W., Pierce, J. M., Seierstad, M. J., Palmer, J. A., Webb, M., Karbarz, M. J., Scott, B. P., Wilson, S. J., Luo, L., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127463 · Cited by 5
Serine Hydrolases in Lipid Homeostasis of the Placenta-Targets for Placental Function?
Berger, N., Allerkamp, H. H., & Wadsack, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126851 · Cited by 5
Activity‐Based Protein Profiling
van Rooden, E. J., Bakker, A. T., Overkleeft, H. S., & van der Stelt, M. (2018) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023406 · Cited by 6
Self-citationOff-target identification by chemical proteomics for the understanding of drug side effects
Song, Y., Luo, L., & Wang, K. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1873134 · Cited by 5
Spatially Resolved Mapping of Monoacylglycerol Lipase Activity in the Brain
van der Vliet, D., Klinkenberg, A. X. Y., Platte, R., Higgins, K., Prokop, S., Huizenga, M. C. W., Kraaijevanger, L., van Egmond, N., Straub, V. M., Kole, M. H. P., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00638 · Cited by 4
van Bergen, W., Žuna, K., Fiala, J., Pohl, E. E., Heck, A. J. R., & Baggelaar, M. P. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00637 · Cited by 4
Self-citationAebi, J. D., Atz, K., Ametamey, S. M., Benz, J., Blaising, J., Butini, S., Campiani, G., Carreira, E. M., Collin, L., de Lago, E., et al. (2024) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2024.499 · Cited by 5
Self-citationGarber, K. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02737-2 · Cited by 5
Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
Kitchigina, V. F. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01148-5 · Cited by 7
Solvent-Induced Protein Precipitation for Drug Target Discovery
Zhang, X., Hu, L., & Ye, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_4 · Cited by 4
Zhu, H., Sharafi, M., Teh, W. P., Bratt, A. S., Buhrlage, S. J., & Marto, J. A. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200113 · Cited by 4
Cramer, S., Johnson, J., Ngo, T., El‐Alfy, A. T., & Stec, J. (2019) · ChemistrySelect · doi:10.1002/slct.201903375 · Cited by 4
Unmodified methodologies in target discovery for small molecule drugs: A rising star
Tang, J., Ou, M., Zheng, Q., & Ding, Y. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.04.013 · Cited by 4
Bass, A. S., Pugsley, M. K., Sannajust, F. J., Yoshinaga, T., & Valentin, J. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.106593 · Cited by 4
The Digital Mouse: why computational modelling of mouse models of disease can improve translationPreprint
van Riel, N. A. W., Müller, R., & Dall’Ara, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.04.075812 · Cited by 4
Activity‐Based Protein Profiling
Panyain, N., Kennedy, C. R., Howard, R. T., & Tate, E. W. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527818242.ch3 · Cited by 4
Nanì, M. F., Rinaldi, M. M., Miraglia, M., Amico, K. R., Cicco, P. D., & Romano, B. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101358 · Cited by 3
Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025
Landolfi, L., Brindisi, M., Onnis, V., Moraca, F., & Catalanotti, B. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2619515 · Cited by 3
Chemical Probes for Investigating the Endocannabinoid System
Hanske, A., Nazaré, M., & Grether, U. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_563 · Cited by 3
Biopharmaceutical development, production, and quality
Benyahia, B., Brumano, L. P., Pessoa, A., & da Silva, F. V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-444-64301-8.00003-2 · Cited by 3
Bed Nucleus of Stria Terminalis (BNST) circuits
Centanni, S. W., Brown, J. A., Williford, K. M., Flook, E. A., Luchsinger, J. R., & Winder, D. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823453-2.00011-4 · Cited by 3
Dargahi, M., Karimi, G., Etemad, L., Alavi, M. S., & Roohbakhsh, A. (2023) · Learning and Motivation · doi:10.1016/j.lmot.2023.101872 · Cited by 3
The Cannabis Conundrum. Look Both Ways before Crossing a Deserted Road
Witek, T. J., & Schwartz, R. M. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201908-581ps · Cited by 3
Toxicant interactions with macromolecular targets
Richardson, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813602-7.00004-1 · Cited by 3
Human adherent cortical organoids in a multiwell formatPreprint
van der Kroeg, M., Bansal, S., Unkel, M., Smeenk, H., Kushner, S. A., & de Vrij, F. M. S. (2024) · eLife · doi:10.7554/elife.98340.1 · Cited by 3
Self-citationPhenotypic approaches for CNS drugs
Sharma, R., Oyagawa, C. R. M., Abbasi, H., Dragunow, M., & Conole, D. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.003 · Cited by 2
Biocompatible Chemistry: A Plug‐and‐Play Toolbox for Chemical Biology Research
Lovato, A. R., Zeng, L., & Zheng, Q. (2025) · ChemBioChem · doi:10.1002/cbic.202500590 · Cited by 2
Arida, R. E., El-Gameel, D., Bassiouni, W., Sandilya, V., Abdallah, S. M., Mechref, Y. S., Abd‐Elrahman, K. S., & EL‐Yazbi, A. F. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70198 · Cited by 2
The emerging role of high-throughput proteomics in advancing precision medicine
You, J., Deng, Y., Chen, L., Wang, L., Guo, Y., Li, Z.-Y., Feng, J., Yu, Y., & Cheng, W. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.02.054 · Cited by 2
Farrell, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2445 · Cited by 2
Understanding and Targeting the Endocannabinoid System with Activity‐Based Protein Profiling
Zhu, N., Janssen, A. P. A., & van der Stelt, M. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200115 · Cited by 2
Self-citationHuman adherent cortical organoids in a multi-well format
van der Kroeg, M., Bansal, S., Unkel, M., Smeenk, H., Kushner, S. A., & de Vrij, F. M. S. (2026) · eLife · doi:10.7554/elife.98340.3 · Cited by 2
Self-citationA Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory
Karimi‐Haghighi, S., Mozafari, R., Chavoshinezhad, S., Khosrowabadi, E., Mahmoudi, M., & Haghparast, A. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00588-6 · Cited by 2
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Luján, M. Á., Kim, Y., Zhang, L., & Cheer, J. F. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_551 · Cited by 2
Treatment of anorexia nervosa with palmitoylethanoamide
Scolnick, B. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.04.010 · Cited by 2
A Swath Label-Free Proteomics insight into the Faah−/− Mouse Liver
Hamid, Z., Summa, M., & Armirotti, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30553-z · Cited by 2
Gaudette, E. V., Watling, S. E., Warsh, J. J., McCluskey, T., Tong, J., Houle, S., Rusjan, P., Rhind, S. G., Bazinet, R. P., Tyndale, R. F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.729 · Cited by 2
The Use of IC 50 for Potency and MTD as Objective in Study BIA 10–2474
van Iersel, M. T. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.995 · Cited by 2
Chaikin, P. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1000 · Cited by 2
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculaturePreprint
Kemble, A. M., Hornsperger, B., Ruf, I., Richter, H. G., Benz, J., Kuhn, B., Heer, D., Wittwer, M., Engelhardt, B., Grether, U., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.490688 · Cited by 2
The future of covalent inhibition
Keserű, G. M., & Erlanson, D. A. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.10.003 · Cited by 1
Fatty acid amide hydrolase, anandamide, and neurological diseases
Fezza, F., Criscuolo, E., Sciscio, M. L. D., & Maccarrone, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00040-1 · Cited by 1
Self-citationJaiswal, S., & Ayyannan, S. R. (2025) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2025.2467438 · Cited by 1
Targeting enzymes with covalent warheads: Beyond cysteine
Patel, D., Sharma, A., & Duncan, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00064-9 · Cited by 1
Altamura, S., Dybeli, E., Lombardi, F., Palumbo, P., Augello, F. R., Topi, S., Cifone, M. G., & Cinque, B. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003233 · Cited by 1
Kumar, S., Pal, A., & Chatterjee, S. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00676-5 · Cited by 1
Xie, W., Chen, Y., Jiang, L., Wu, X., Qi, Z., Shuai, T., Yang, M., Wang, Z., Gao, J., Zhu, Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02841 · Cited by 1
Couttas, T. A., Hoffmann, A., Jieu, B., Golla, F. R., Shepherd, C. E., Leweke, F. M., & Rohleder, C. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04120-4 · Cited by 1
Direct Mechanochemical Oxidation: Sustainable Access to Azine N ‐Oxides
Baykova, S. O., Solodyankina, O. V., Vasileva, M. S., Baykov, S. V., & Boyarskiy, V. P. (2026) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.70456 · Cited by 1
Rossetti, T., Han, L., Barasa, L., Tran, T., Hwang, S., O’Reilly, M., Xu, Z., & Thompson, P. R. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00314 · Cited by 1
Will Labour help us transition away from pre-clinical animal research?
Pound, P., & Ritskes-Hoitinga, M. J. (2024) · BMJ · doi:10.1136/bmj.q1600 · Cited by 1
Burt, T., & Combes, R. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813697-3.00026-3 · Cited by 1
Modulation of endocannabinoid system: Success lies in the failures
Medhi, B., Kumar, S., Sarma, P., Kumar, H., & Prakash, A. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_541_18 · Cited by 1
Assays to Characterize the Cellular Pharmacology of a Chemical Probe
Stefaniak, J., Galan, S. R. G., & Huber, K. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00247 · Cited by 1
Cannabinoid treatment of opiate addiction
McLemon, E., & Chesworth, R. (2021) · Neuroanatomy and Behaviour · doi:10.35430/nab.2021.e14 · Cited by 1
Activity‐Based Protein Profiling
(2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp00145 · Cited by 1
Tunable nucleofugality in carbamoyl-bearing covalent cholinesterase inhibitorsPreprint
Meden, A., Knez, D., Chen, X., Li, L., Brazzolotto, X., Zorman, M., Pišlar, A. H., Perdih, A., Modeste, F., Dalle, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671340 · Cited by 1
Metabolism of N ‐Acylethanolamines: To Phase II and Back Again
Karlsson, J., & Fowler, C. J. (2017) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0027664
Highly Efficient Cell‐Penetrating Probes of Protein Arginine Deiminases for Functional Proteomics
Pathak, S. K. (2018) · ChemBioChem · doi:10.1002/cbic.201800257
Cannabinoids as a Therapeutic Approach in Multiple Sclerosis
Pryce, G., & Baker, D. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00241
Endocannabinoid turnover (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Alexander, S. P. H., Doherty, P., Fowler, C. J., Gertsch, J., & van der Stelt, M. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f943/2019.4
Hydrolases (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Alexander, S. P. H., Doherty, P., Fairlie, D. P., Fowler, C. J., Overall, C. M., Rawlings, N. D., Southan, C., & Turner, A. J. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f799/2019.4
Ogasawara, D. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00186-1
Self-citationIn Vivo Targeting of Endogenous Proteins with Reactive Small Molecules
Shindo, N., & Ojida, A. (2019) · Wiley eBooks · doi:10.1002/9783527344406.ch10
Fatty Acid Amide Hydrolase – Computational Studies
Lodola, A., & Mor, M. (2020) · Springer eBooks · doi:10.1007/978-3-642-35943-9_244-1
Cannabinoid treatment of opiate addiction
McLemon, E., & Chesworth, R. (2021) · doi:10.23668/psycharchives.4898 · Cited by 1
Endocannabinoid turnover in GtoPdb v.2021.3
Alexander, S. P. H., Doherty, P., Fowler, C. J., Gertsch, J., & van der Stelt, M. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f943/2021.3
Uyama, T., & Ueda, N. (2020) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.58.599
Bortolato, M., & Cadeddu, R. (2022) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.12.008
Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10‐2474
Cerqueira, N. M. F. S. A., Neves, M., Rocha, J. F., Silva, P. S., & Palma, P. N. (2022) · ChemBioChem · doi:10.1002/cbic.202200166
Metadata
- Authors
- van Esbroeck, A. C. M., Janssen, A. P. A., Cognetta, A. B., Ogasawara, D., Shpak, G., van der Kroeg, M., Kantae, V., Baggelaar, M. P., de Vrij, F. M. S., Deng, H., Allarà, M., Fezza, F., Lin, Z., van der Wel, T., Soethoudt, M., Mock, E. D., den Dulk, H., Baak, I. L., Florea, B. I., Hendriks, G., De Petrocellis, L., Overkleeft, H. S., Hankemeier, T., De Zeeuw, C. I., Di Marzo, V., Maccarrone, M., Cravatt, B. F., Kushner, S. A., & van der Stelt, M.
- Affiliations
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, Netherlands.
- Leiden University (NL)
- Scripps Research Institute (US)
- Erasmus MC (NL)
- Department of Psychiatry, Erasmus University Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Istituto di Chimica Biomolecolare (IT)
- University of Rome Tor Vergata (IT)
- Toxys B.V., Robert Boyleweg 4, 2333 CG, Leiden, Netherlands.
- Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche (CNR), Via Campi Flegrei 34, Comprensorio Olivetti, 80078 Pozzuoli, Italy.
- Department of Neuroscience, Erasmus Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Università Campus Bio-Medico (IT)
- Corresponding author
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Kushner, Steven A.
- ORCID
- van Esbroeck, Annelot C. M.
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Shpak, Guy
- van der Kroeg, Mark
- Kantae, Vasudev
- Baggelaar, Marc P.
- Deng, Hui
- Allarà, Marco
- Fezza, Filomena
- Lin, Zhanmin
- van der Wel, Tom
- Soethoudt, Marjolein
- Mock, Elliot D.
- den Dulk, Hans
- Baak, Ilse L.
- Florea, Bogdan I.
- Hendriks, Giel
- De Petrocellis, Luciano
- Overkleeft, Herman S.
- Hankemeier, Thomas
- Di Marzo, Vincenzo
- Maccarrone, Mauro
- Cravatt, Benjamin F.
- Kushner, Steven A.
- van der Stelt, Mario
- Venue
- Science
- Published
- 2017-06-09
- Volume
- 356
- Issue
- 6342
- Pages
- 1084-1087
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5641481
- OpenAlex
- W2621737540
- Cited by
- 332
- References
- 40
- Citations by year
- 2026: 23 · 2025: 20 · 2024: 33 · 2023: 25 · 2022: 27 · 2021: 33 · 2020: 63 · 2019: 50 · 2018: 47 · 2017: 10
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Leiden Repository (Leiden University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Funders
- National Institutes of Health (award304469, DA033760)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- FAAH inhibitors, off-target effects, lipase inhibition, neurotoxicity, activity-based protein profiling, fatty acid amide hydrolase, lipid metabolism, cortical neurons, drug safety
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Analgesics, Cross Reactions, Cyclic N-Oxides, Humans, Neurons, Pyridazines, Pyridines, Anti-Anxiety Agents, Urea, Clinical Trials, Phase I as Topic, Cell Line, Tumor, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
